Literature DB >> 6969747

The in vitro response of human lymphocytes to Pneumocystis carinii antigen.

H G Herrod, W R Valenski, D R Woods, L L Pifer.   

Abstract

Pneumocystis carinii pneumonitis (PCP) is a major complication in the immunocompromised host. Recent evidence suggests that most normal individuals have detectable antibody against this organism. The role of the various components of the immune system in protecting the host from acute PCP is unclear. We have examined the in vitro proliferative response of lymphocytes from normal adults to P. carinii antigen. Fourteen of 16 subjects had a positive response with stimulation indices greater than 3. This response was due primarily to thymus-derived (T cell) lymphocytes and was dependent upon the presence of adherent cells. The response was most likely not due to a mitogenic component in our antigen preparation, since lymphocytes from only 2 of 16 cord blood specimens had stimulation indices greater than 3.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6969747

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Pneumocystis carinii: a misunderstood opportunist.

Authors:  L L Pifer
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

3.  Pneumocystis lung disease in homosexual men.

Authors: 
Journal:  West J Med       Date:  1982-11

4.  Preservation of clonal heterogeneity of the Pneumocystis carinii-specific CD4 T cell repertoire in HIV infected, asymptomatic individuals.

Authors:  G Li Pira; D Fenoglio; L Bottone; P Terranova; E Pontali; F Caroli; M Seri; J-C Cailliez; G Koopman; R Accolla; F del Galdo; G Abbate; R de Palma; F Manca
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice.

Authors:  P D Walzer; M E Rutledge
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Detection of specific antibody by enzyme-linked immunosorbent assay and antigenemia by counterimmunoelectrophoresis in humans infected with Pneumocystis carinii.

Authors:  S E Maddison; G V Hayes; S B Slemenda; L G Norman; M H Ivey
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

7.  Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii.

Authors:  T Furuta; K Ueda; K Fujiwara; K Yamanouchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

8.  Purification and characterization of a major human Pneumocystis carinii surface antigen.

Authors:  B Lundgren; G Y Lipschik; J A Kovacs
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection.

Authors:  D J Fisher; F Gigliotti; M Zauderer; A G Harmsen
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndrome.

Authors:  L L Pifer; H B Niell; S B Langdon; S Baltz; S T Clark; C C Edwards; D R Woods
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.